Related references
Note: Only part of the references are listed.Extract of Ginkgo biloba Treatment for Tardive Dyskinesia in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
Wu-Fang Zhang et al.
JOURNAL OF CLINICAL PSYCHIATRY (2011)
Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology
John T. O'Brien et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2011)
Specific memory effects of Ginkgo biloba extract EGb 761 in middle-aged healthy volunteers
R. Kaschel
PHYTOMEDICINE (2011)
Personality and medication non-adherence among older adults enrolled in a six-year trial
Anthony Jerant et al.
BRITISH JOURNAL OF HEALTH PSYCHOLOGY (2011)
The Ginkgo biloba extract EGb 761® and its main constituent flavonoids and ginkgolides increase extracellular dopamine levels in the rat prefrontal cortex
T. Yoshitake et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Review and meta-analysis of usage of ginkgo as an adjunct therapy in chronic schizophrenia
Vidhi Singh et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2010)
Early Alzheimer’s trials: New developments
B. Vellas et al.
Journal of Nutrition Health & Aging (2010)
Effectiveness of Standardized Ginkgo biloba Extract on Cognitive Symptoms of Dementia with a Six-Month Treatment: A Bivariate Random Effect Meta-Analysis
B. -S. Wang et al.
PHARMACOPSYCHIATRY (2010)
Effects of Ginkgo biloba in dementia: systematic review and meta-analysis
Stefan Weinmann et al.
BMC GERIATRICS (2010)
Building a Better Antipsychotic: Receptor Targets for the Treatment of Multiple Symptom Dimensions of Schizophrenia
Dennis H. Kim et al.
NEUROTHERAPEUTICS (2009)
Ginkgo biloba extract (EGb761®) influences monoaminergic neurotransmission via inhibition of NE uptake, but not MAO activity after chronic treatment
Christian J. Fehske et al.
PHARMACOLOGICAL RESEARCH (2009)
Chronic administration of a Ginkgo biloba leaf extract facilitates acquisition but not performance of a working memory task
Elham Satvat et al.
PSYCHOPHARMACOLOGY (2009)
GuidAge study: A 5-year double blind, randomised trial of EGb 761 for the prevention of Alzheimer's disease in elderly subjects with memory complaints. I. Rationale, design and baseline data
Sandrine Andrieu et al.
CURRENT ALZHEIMER RESEARCH (2008)
Role of the Central Cholinergic System in the Therapeutics of Schizophrenia
Alvin Terry et al.
Current Neuropharmacology (2008)
EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice:: role of oxidative stress
Patricia Rojas et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2008)
Ginkgo biloba for Prevention of Dementia A Randomized Controlled Trial
Steven T. DeKosky et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
A randomized placebo-controlled trial of Ginkgo biloba for the prevention of cognitive decline
H. H. Dodge et al.
NEUROLOGY (2008)
Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761)
Reham Abdel-Kader et al.
PHARMACOLOGICAL RESEARCH (2007)
Vasodilators and nootropics as predictors of dementia and mortality in the PAQUID cohort
Jean-Francois Dartigues et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2007)
Ginkgo biloba leave extract:: Biological, medicinal, and toxicological effects
Po-Chuen Chan et al.
JOURNAL OF ENVIRONMENTAL SCIENCE AND HEALTH PART C-ENVIRONMENTAL CARCINOGENESIS & ECOTOXICOLOGY REVIEWS (2007)
The in vivo synaptic plasticity mechanism of EGb 761-induced enhancement of spatial learning and memory in aged rats
Yongfu Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats:: neurobehavioural, neurochemical and immunohistochemical evidences
M Ahmad et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Presynaptic D1 dopamine receptors in primate prefrontal cortex:: Target-specific expression in the glutamatergic synapse
CD Paspalas et al.
JOURNAL OF NEUROSCIENCE (2005)
Enhancement of working memory in aged monkeys by a sensitizing regimen of dopamine D1 receptor stimulation
SA Castner et al.
JOURNAL OF NEUROSCIENCE (2004)
The role of α1- and α2-adrenoreceptors on venlafaxine-induced elevation of extracellular serotonin, noradrenaline and dopamine levels in the rat prefrontal cortex and hippocampus
P Weikop et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2004)
Determination of serotonin, noradrenaline, dopamine and their metabolites in rat brain extracts and microdialysis samples by column liquid chromatography with fluorescence detection following derivatization with benzylamine and 1,2-diphenylethylenediamine
T Yoshitake et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2004)
Ginkgo biloba normalises stress-elevated alterations in brain catecholamines, serotonin and plasma corticosterone levels
ZA Shah et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2003)
The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: Recent challenges and their implications for novel drug development
AV Terry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Neuroprotective effects of Ginkgo biloba extract
B Ahlemeyer et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2003)
Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment
RW Stackman et al.
EXPERIMENTAL NEUROLOGY (2003)
Biologically active secondary metabolites from Ginkgo biloba
E Bedir et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)
In vivo regulation of cerebral monoamine oxidase activity in senescent controls and chronically stressed mice by long-term treatment with Ginkgo biloba extract (EGb 761)
MC Pardon et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2000)
Ginkgo Biloba Abolishes Aggression in Mice Lacking MAO A
Jean C. Shih et al.
ANTIOXIDANTS & REDOX SIGNALING (2000)
D-1 receptors in prefrontal cells and circuits
PS Goldman-Rakic et al.
BRAIN RESEARCH REVIEWS (2000)
Share Paper
